Emmaus Life Sciences, Inc. (EMMA) shareholders
Close on Oct 19, 2026Market cap $6.03MP/E –Yield –
Ownership
Who owns Emmaus Life Sciences's shares
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Seah H. Lim, M.D., Ph.D. | 4,147,426 | 6.50% | 13G (passive) amendment | Dec 31, 2024 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Willis C. Lee | CEO, Director | 1,326,485 | 1.89% | Sep 2, 2026 |
| Henry Huy Du | Director | – | – | Apr 21, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Willis C. Lee CEO, Director | Aug 31, 2026 | Buy | +100,000 | $0.05 | $5.00K | 690,167 |
| Willis C. Lee CEO, Director | Aug 28, 2026 | Buy | +94,767 | $0.06 | $5.69K | 590,167 |
| Willis C. Lee CEO, Director | Aug 27, 2026 | Buy | +50,000 | $0.05 | $2.50K | 495,400 |
| Willis C. Lee CEO, Director | Aug 25, 2026 | Buy | +46,000 | $0.04 | $1.84K | 445,400 |
| Willis C. Lee CEO, Director | Aug 29, 2025 | Buy | +170,000 | $0.01 | $1.70K | 275,400 |
| Willis C. Lee CEO, Director | May 30, 2025 | Buy | +70,000 | $0.02 | $1.40K | 229,400 |
| Seah H. Lim Director | Sep 16, 2024 | Buy | +20,000 | $0.04 | $800 | 4,606,626 |
| Willis C. Lee Co-President & COO, Director | Feb 29, 2024 | Buy | +77,000 | $0.13 | $10.01K | 159,400 |
| Willis C. Lee Co-President & COO, Director | Feb 28, 2024 | Buy | +15,000 | $0.12 | $1.80K | 82,400 |
| Willis C. Lee Co-President & COO, Director | Feb 27, 2024 | Buy | +10,000 | $0.13 | $1.30K | 67,400 |
| Willis C. Lee Co-President & COO, Director | Feb 26, 2024 | Buy | +13,200 | $0.12 | $1.58K | 57,400 |
| Seah H. Lim Director | Dec 20, 2023 | Sale | −32,500 | $0.05 | $1.63K | 4,586,626 |
| Seah H. Lim Director | Dec 15, 2023 | Sale | −6,000 | $0.11 | $660 | 171,700 |
| Seah H. Lim Director | Dec 15, 2023 | Other | +4,447,426 | $0.29 | $1.29M | 4,619,126 |
| Wei Peu ZEN Director | Dec 15, 2023 | Other | +3,760,983 | $0.29 | $1.09M | 4,768,817 |
| Willis C. Lee COO, Director | Nov 30, 2023 | Buy | +59,400 | $0.12 | $7.13K | 395,124 |
| Willis C. Lee COO, Director | Nov 30, 2023 | Buy | +7,417 | $0.12 | $890 | 395,124 |
| Willis C. Lee COO, Director | Nov 29, 2023 | Buy | +36,000 | $0.12 | $4.32K | 335,724 |
| Willis C. Lee COO, Director | Nov 29, 2023 | Buy | +4,325 | $0.12 | $519 | 335,724 |
| Willis C. Lee COO, Director | Nov 28, 2023 | Buy | +12,000 | $0.12 | $1.44K | 299,724 |
| Willis C. Lee COO, Director | Nov 28, 2023 | Buy | +1,470 | $0.12 | $176 | 299,724 |
| Willis C. Lee COO, Director | Nov 14, 2023 | Buy | +1,100 | $0.12 | $132 | 44,200 |
| Willis C. Lee COO, Director | Nov 14, 2023 | Buy | +132 | $0.12 | $16 | 44,200 |
| Seah H. Lim Director | Sep 5, 2023 | Buy | +1,700 | $0.15 | $255 | 177,700 |
| Willis C. Lee COO, Director | Aug 31, 2023 | Buy | +6,000 | $0.15 | $900 | 43,100 |
| Willis C. Lee COO, Director | Aug 31, 2023 | Buy | +900 | $0.15 | $135 | 43,100 |
| Seah H. Lim Director | Aug 30, 2023 | Buy | +20,000 | $0.15 | $3.00K | 176,000 |
| Willis C. Lee COO, Director | Aug 25, 2023 | Buy | +6,500 | $0.21 | $1.37K | 37,100 |
| Seah H. Lim Director | Aug 25, 2023 | Buy | +92,100 | $0.27 | $24.87K | 156,000 |
| Willis C. Lee COO, Director | Aug 25, 2023 | Buy | +1,365 | $0.21 | $287 | 37,100 |
| Willis C. Lee COO, Director | May 31, 2023 | Buy | +28,700 | $0.29 | $8.32K | 30,600 |
| Yutaka Niihara Chairman and CEO, Director, 10% owner | Nov 30, 2022 | Buy | +22,900 | $0.41 | $9.39K | 12,040,857 |
| Yutaka Niihara Chairman and CEO, Director, 10% owner | Nov 29, 2022 | Buy | +14,700 | $0.38 | $5.59K | 12,017,957 |
| Yutaka Niihara Chairman and CEO, Director, 10% owner | Nov 28, 2022 | Buy | +5,000 | $0.35 | $1.75K | 12,003,257 |
| Yutaka Niihara Chairman and CEO, Director, 10% owner | Nov 4, 2022 | Buy | +7,500 | $0.45 | $3.38K | 11,998,257 |
| Yutaka Niihara Chairman and CEO, Director, 10% owner | Nov 3, 2022 | Buy | +2,500 | $0.45 | $1.13K | 11,990,757 |
| Yutaka Niihara Chairman and CEO, Director, 10% owner | Nov 2, 2022 | Buy | +15,000 | $0.43 | $6.45K | 11,988,257 |
| Yutaka Niihara Chairman and CEO, Director, 10% owner | Nov 1, 2022 | Buy | +5,000 | $0.43 | $2.15K | 11,973,257 |
| Yutaka Niihara Chairman and CEO, Director, 10% owner | Oct 31, 2022 | Buy | +7,500 | $0.45 | $3.38K | 11,968,257 |
| Yutaka Niihara Chairman and CEO, Director, 10% owner | Oct 28, 2022 | Buy | +7,500 | $0.42 | $3.15K | 11,960,757 |
| Yutaka Niihara Chairman and CEO, Director, 10% owner | Oct 27, 2022 | Buy | +22,500 | $0.27 | $6.08K | 11,953,257 |
| Yutaka Niihara Chairman and CEO, Director, 10% owner | Oct 26, 2022 | Buy | +11,900 | $0.27 | $3.21K | 11,930,757 |
| Yutaka Niihara Chairman and CEO, Director, 10% owner | Oct 25, 2022 | Buy | +20,000 | $0.26 | $5.20K | 11,918,857 |
| Yutaka Niihara Chairman and CEO, Director, 10% owner | Oct 24, 2022 | Buy | +7,500 | $0.22 | $1.65K | 11,898,857 |
| Yutaka Niihara Chairman and CEO, Director, 10% owner | Oct 21, 2022 | Buy | +10,000 | $0.19 | $1.90K | 11,891,357 |
| Yutaka Niihara Chairman and CEO, Director, 10% owner | Oct 20, 2022 | Buy | +30,000 | $0.18 | $5.40K | 11,881,357 |
| Yutaka Niihara Chairman and CEO, Director, 10% owner | Oct 19, 2022 | Buy | +25,000 | $0.16 | $4.00K | 11,851,357 |
| Yutaka Niihara Chairman and CEO, Director, 10% owner | Oct 18, 2022 | Buy | +30,000 | $0.19 | $5.70K | 11,826,357 |
| Yutaka Niihara Chairman and CEO, Director, 10% owner | Oct 17, 2022 | Buy | +15,000 | $0.20 | $3.00K | 11,796,357 |
| Yutaka Niihara Chairman and CEO, Director, 10% owner | Oct 14, 2022 | Buy | +35,000 | $0.17 | $5.95K | 11,781,357 |
| Yutaka Niihara Chairman and CEO, Director, 10% owner | Oct 13, 2022 | Buy | +62,500 | $0.18 | $11.25K | 11,746,357 |
| Yutaka Niihara Chairman and CEO, Director, 10% owner | Oct 12, 2022 | Buy | +160,000 | $0.08 | $12.80K | 11,683,857 |
| Yutaka Niihara Chairman and CEO, Director, 10% owner | Oct 11, 2022 | Buy | +5,000 | $0.09 | $450 | 11,523,857 |
| Yutaka Niihara Chairman and CEO, Director, 10% owner | Oct 11, 2022 | Buy | +130,000 | $0.09 | $11.70K | 11,518,857 |
| Yutaka Niihara Chairman and CEO, Director, 10% owner | Oct 10, 2022 | Buy | +10,000 | $0.09 | $900 | 11,388,857 |
| Seah H. Lim Director | Oct 9, 2022 | Buy | +25,400 | $0.11 | $2.79K | 63,900 |
| Yutaka Niihara Chairman and CEO, Director, 10% owner | Oct 7, 2022 | Buy | +4,000 | $0.13 | $520 | 11,378,857 |
| Yutaka Niihara Chairman and CEO, Director, 10% owner | Oct 6, 2022 | Buy | +5,000 | $0.15 | $750 | 11,374,857 |
| Yutaka Niihara Chairman and CEO, Director, 10% owner | Oct 5, 2022 | Buy | +10,000 | $0.15 | $1.50K | 11,369,857 |
| Yutaka Niihara Chairman and CEO, Director, 10% owner | Oct 4, 2022 | Buy | +5,000 | $0.16 | $800 | 11,359,857 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Emmaus Life Sciences's stock actually held short. Settlement fails (shares not delivered on time) peaked at 40,000 shares on Aug 24, 2026 over the last 90 days.
See a number that looks wrong?